The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin

Antivir Ther. 2004 Dec;9(6):1031-3.
No abstract available

MeSH terms

  • Adult
  • CD4 Lymphocyte Count
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / virology
  • HIV Protease Inhibitors / administration & dosage*
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / physiology
  • Humans
  • Male
  • RNA, Viral / blood
  • Rifampin / administration & dosage*
  • Rifampin / therapeutic use
  • Ritonavir / administration & dosage*
  • Ritonavir / adverse effects
  • Ritonavir / therapeutic use
  • Saquinavir / administration & dosage*
  • Saquinavir / adverse effects
  • Saquinavir / therapeutic use
  • Treatment Outcome
  • Tuberculosis / complications*
  • Tuberculosis / drug therapy

Substances

  • HIV Protease Inhibitors
  • RNA, Viral
  • Saquinavir
  • Ritonavir
  • Rifampin